ARTICLE | Company News
Odyssey, Merck deal
October 18, 2004 7:00 AM UTC
Under an expansion of an existing deal, Odyssey will use its protein-fragmentation complementation assay (PCA) and high throughput systems biology to characterize the mechanisms of action in human cel...